These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31920110)

  • 1. Incidence and Risk for Developing Proliferative Diabetic Retinopathy after Photocoagulation for Diabetic Maculopathy.
    Bek T
    Curr Eye Res; 2020 Aug; 45(8):986-991. PubMed ID: 31920110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Acta Ophthalmol; 2013 May; 91(3):251-8. PubMed ID: 22176513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute retinal pigment epithelium detachments after photocoagulation.
    Moysidis SN; Vajzovic L; Gregori G; Goldberg JL
    Retina; 2014 Apr; 34(4):749-60. PubMed ID: 24013258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes.
    Bek T; Kjaergaard J
    Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
    Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
    Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in retinal vascular parameters associated with successful panretinal photocoagulation in proliferative diabetic retinopathy: A prospective clinical interventional study.
    Torp TL; Kawasaki R; Wong TY; Peto T; Grauslund J
    Acta Ophthalmol; 2018 Jun; 96(4):405-410. PubMed ID: 29193789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control.
    Chantelau E
    Diabetes Metab; 2001 Jun; 27(3):366-71. PubMed ID: 11431602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF Therapy for Persistent Neovascularization after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy.
    Mehanna CJ; Abdul Fattah M; Haddad S; Tamim H; Ghazi N; Salti H
    Ophthalmol Retina; 2019 Jun; 3(6):473-477. PubMed ID: 31174668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
    Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
    JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
    Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
    JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing metabolic variability increases the risk for vitrectomy in proliferative diabetic retinopathy.
    Bek T; Nielsen MS; Klug SE; Eriksen JE
    Int Ophthalmol; 2022 Mar; 42(3):757-763. PubMed ID: 34625890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.
    Chappelow AV; Tan K; Waheed NK; Kaiser PK
    Am J Ophthalmol; 2012 Jan; 153(1):137-42.e2. PubMed ID: 21937017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
    Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous resolution of macular edema after panretinal photocoagulation in florid proliferative diabetic retinopathy.
    Gaucher D; Fortunato P; LeCleire-Collet A; Bourcier T; Speeg-Schatz C; Tadayoni R; Massin P
    Retina; 2009 Oct; 29(9):1282-8. PubMed ID: 19629019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.